-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Raises Price Target to $146

Benzinga·06/15/2026 14:06:18
Listen to the news
Citizens analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises the price target from $140 to $146.